A detailed history of Tufton Capital Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Tufton Capital Management holds 10,753 shares of BSX stock, worth $983,899. This represents 0.17% of its overall portfolio holdings.

Number of Shares
10,753
Previous 11,342 5.19%
Holding current value
$983,899
Previous $873,000 3.21%
% of portfolio
0.17%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$72.96 - $84.0 $42,973 - $49,476
-589 Reduced 5.19%
10,753 $901,000
Q2 2024

Jul 31, 2024

BUY
$67.33 - $77.71 $5,184 - $5,983
77 Added 0.68%
11,342 $873,000
Q4 2023

Jan 31, 2024

SELL
$48.64 - $57.81 $486 - $578
-10 Reduced 0.09%
11,265 $651,000
Q3 2023

Oct 30, 2023

BUY
$50.19 - $54.68 $9,285 - $10,115
185 Added 1.67%
11,275 $595,000
Q2 2023

Jul 28, 2023

SELL
$49.72 - $54.64 $198,880 - $218,560
-4,000 Reduced 26.51%
11,090 $599,000
Q1 2023

Apr 19, 2023

SELL
$45.09 - $50.03 $2,254 - $2,501
-50 Reduced 0.33%
15,090 $754,000
Q3 2022

Oct 21, 2022

BUY
$36.71 - $109.66 $4,405 - $13,159
120 Added 0.8%
15,140 $586,000
Q2 2022

Jul 20, 2022

BUY
$35.24 - $47.1 $11,453 - $15,307
325 Added 2.21%
15,020 $559,000
Q1 2022

Apr 25, 2022

BUY
$40.9 - $45.1 $11,247 - $12,402
275 Added 1.91%
14,695 $650,000
Q4 2021

Jan 28, 2022

BUY
$38.07 - $44.87 $14,276 - $16,826
375 Added 2.67%
14,420 $612,000
Q3 2021

Oct 21, 2021

BUY
$41.23 - $45.88 $6,184 - $6,882
150 Added 1.08%
14,045 $609,000
Q2 2021

Jul 29, 2021

BUY
$38.58 - $44.24 $166,858 - $191,338
4,325 Added 45.19%
13,895 $594,000
Q1 2021

Apr 22, 2021

BUY
$35.27 - $39.67 $337,533 - $379,641
9,570 New
9,570 $369,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Tufton Capital Management Portfolio

Follow Tufton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tufton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Tufton Capital Management with notifications on news.